Caplin Point Lab Share Price

Caplin Point Lab Share Price

NSE: CAPLIPOINT
|
Pharmaceuticals

₹ 2,460.80

-₹88.00 (-3.45%)
1D
Last updated 09 Oct, 2026, 15:55 IST

Caplin Point Lab Share Price Today

As of 12 Oct 2026, Caplin Point Lab share price is ₹2,460.80. The stock opened at ₹2,541.00, compared to its previous close of ₹2,548.80. During today's trading session, Caplin Point Lab share price moved in the range of ₹2,431.10 to ₹2,576.40, with an average price of ₹2,503.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,500.30 and a high of ₹2,990.00. On the performance front, Caplin Point Lab share price has increased by 48.06% over the last six months and is up 21.46% on a year-on-year basis.

₹2,431.10
3.45% down today
₹2,576.40
1D LOW
1D HIGH

Caplin Point Lab Returns Calculator

Volume
1,88,948
Average traded price
₹2,478.96
Last traded time
03:55:57 09 Oct
Last traded quantity
50
Circuit
L
H
₹1,968.70
₹2,952.90
52-week
L
H
₹1,500.30
₹2,990.00
Mkt Cap Cr
18,695.46
P/E
27.57
P/B
5.55
ROA
16.76%
ROE
17.88%
ROCE
22.3%
Quick Ratio
5.59
EV/EBITDA
19.61
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Caplin Point Lab has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Caplin Point Lab appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Caplin Point Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,21,539.1634.795.0411.19%13.74%17.33%2.3121.42
Divis Laboratories2,47,576.0084.6414.7714.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.2221.084.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,11,231.6524.224.18.57%18.59%17.35%0.9114.87
Laurus Labs1,09,796.85100.720.7210.38%16.77%16.14%0.6853.86
Cipla1,05,289.7831.373.067.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories99,752.6431.332.625.48%11.07%12.54%1.3515.86
Mankind Pharma97,850.3847.326.07.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,014.4726.152.566.34%9.25%11.76%1.1512.47
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Caplin Point Lab

Caplin Point Lab Share Price
ISIN
INE475E01026
Sector Market Cap
₹ 18,695.46 Cr

Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.

Caplin Point Lab Financial Highlights

  • Revenue: Caplin Point Lab reported revenue of ₹2,302.73 crore in FY26 vs ₹2,033.90 crore in FY25. It showed an increase of 13.22% on a yearly basis.
  • Operating Profit: Caplin Point Lab reported an operating profit of ₹802.79 crore in FY26 vs ₹676.78 crore in FY25. It showed an increase of 18.62% on a year-on-year basis.
  • Net Profit: Caplin Point Lab reported a net profit of ₹649.73 crore in FY26 vs ₹541.09 crore in FY25. It showed an increase of 20.08% on a yearly basis.

Caplin Point Lab Quarterly Result Highlights

  • Caplin Point Lab reported revenue of ₹643.91 crore in Jun 2026, compared with ₹628.52 crore in Mar 2026, representing an increase of 2.45% on a quarter-on-quarter (QoQ) basis.
  • Caplin Point Lab reported an operating profit of ₹225.22 crore in Jun 2026, compared with ₹213.44 crore in Mar 2026, representing an increase of 5.52% on a quarter-on-quarter (QoQ) basis.
  • Caplin Point Lab reported a profit of ₹179.09 crore in Jun 2026, compared with ₹172.88 crore in Mar 2026, reflecting an increase of 3.59% on a QoQ basis.
  • The earnings per share (EPS) of Caplin Point Lab stood at ₹84.36 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
70.57%
FII
5.75%
Other DII
0.47%
Retail and other
21.18%
Mutual funds
2.03%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20256.51%
Dec 20256.59%
Mar 20266.15%
Jun 20265.75%
1 day
-3.45%
1 week
-6.50%
1 month
-9.63%
1 year
+21.46%
3 years
+133.69%
5 years
+184.03%
Day
Open / Close
Change %
09 Oct 26
₹2,541.00 / ₹2,460.80
-3.45%
08 Oct 26
₹2,649.10 / ₹2,548.80
-3.79%
07 Oct 26
₹2,675.20 / ₹2,649.10
-1.14%
06 Oct 26
₹2,611.00 / ₹2,679.70
+2.91%
Show more

Caplin Point Lab Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,187.19₹1,937.47₹1,694.10₹1,466.73
Other Income₹115.54₹96.43₹66.94₹55.98
Total Revenue₹2,302.73₹2,033.90₹1,761.04₹1,522.71
Total Expenses₹1,499.98₹1,357.11₹1,196.88₹1,071.44
Profit Before Tax₹802.79₹676.78₹564.43₹451.35
Tax₹153.06₹135.69₹103.01₹74.36
Profit After Tax₹649.73₹541.09₹461.42₹376.99
EPS - Basic₹84.36₹70.57₹60.19₹49.62
EPS - Diluted₹84.11₹70.25₹59.90₹49.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹802.79₹676.78₹564.43₹451.35
Income before WC changes₹776.71₹682.29₹566.83₹463.12
Change in Assets-₹319.42-₹117.48-₹228.22-₹178.01
Change in Liabilities₹210.45-₹4.80₹88.78₹74.26
Change in WC-₹108.97-₹122.28-₹139.44-₹103.75
Cash flow from Operations₹523.24₹432.37₹318.39₹271.37
Cash flow from Investing-₹582.30-₹334.73-₹320.04-₹217.58
Cash flow from Financing-₹46.46-₹38.32-₹38.07-₹28.17
Total Cash Flow-₹105.52₹59.32-₹39.72₹25.62
Cash (Start of the year)₹199.45₹138.70₹177.56₹150.76
Cash (End of the year)₹94.18₹199.45₹138.70₹177.56

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,459.82₹1,073.90₹805.20₹639.21
Current Assets₹2,585.66₹2,133.95₹1,892.92₹1,552.19
Total Assets₹4,045.48₹3,207.85₹2,698.12₹2,191.40
Current Liabilities₹385.96₹305.99₹330.85₹268.00
Net Current Asset₹2,199.70₹1,827.96₹1,562.07₹1,284.19
Non-Current Liabilities₹28.72₹15.47₹20.44₹16.13
Equity Capital₹3,630.80₹2,886.39₹2,346.83₹1,907.27
Total Equity & Liabilities₹4,045.48₹3,207.85₹2,698.12₹2,191.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹738.33₹752.41₹625.09₹528.61
Other Income₹195.37₹134.59₹105.84₹99.00
Total Revenue₹933.70₹887.00₹730.93₹627.61
Total Expenses₹426.18₹445.33₹365.19₹334.46
Profit Before Tax₹507.52₹441.67₹365.74₹293.15
Tax₹110.94₹102.18₹82.03₹58.89
Profit After Tax₹396.58₹339.49₹283.71₹234.26
EPS - Basic₹52.17₹44.67₹37.36₹30.89
EPS - Diluted₹52.02₹44.67₹37.18₹30.62

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹507.52₹441.67₹365.74₹293.15
Income before WC changes₹363.71₹357.20₹297.17₹233.58
Change in Assets-₹99.88-₹36.74-₹74.52-₹54.85
Change in Liabilities₹49.06-₹20.75-₹24.55₹43.41
Change in WC-₹50.82-₹57.49-₹99.07-₹11.44
Cash flow from Operations₹203.48₹195.87₹111.01₹157.10
Cash flow from Investing-₹213.47-₹140.20-₹118.94-₹86.67
Cash flow from Financing-₹45.81-₹38.10-₹34.26-₹30.42
Total Cash Flow-₹55.80₹17.57-₹42.19₹40.01
Cash (Start of the year)₹99.64₹80.64₹122.02₹81.01
Cash (End of the year)₹44.09₹99.64₹80.64₹122.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,235.86₹988.79₹819.21₹641.48
Current Assets₹975.88₹825.69₹703.10₹661.70
Total Assets₹2,211.74₹1,814.48₹1,522.31₹1,303.18
Current Liabilities₹144.17₹99.85₹118.87₹146.85
Net Current Asset₹831.71₹725.84₹584.23₹514.85
Non-Current Liabilities₹17.07₹13.70₹13.29₹16.42
Equity Capital₹2,050.50₹1,700.93₹1,390.15₹1,139.91
Total Equity & Liabilities₹2,211.74₹1,814.48₹1,522.31₹1,303.18
* All values are in INR Crore
Qty
Bid
50
2460.8
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 50
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.2
Neutral
ATR (14)
115.67
Neutral
STOCH(9,6)
6.77
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
23.28
Bearish
UO(9)
44.53
Neutral
ROC(12)
-11.4
Bearish
WillR(14)
-94.69
Bullish
Period
Simple value
Exponential vaue
5D
2588.48
2573.86
10D
2672.38
2632.75
20D
2698.4
2666.18
50D
2634.68
2625.55
100D
2508.97
2479.84
Volume trend — traded volume by day
9 Oct1L
8 Oct0L
7 Oct1L
6 Oct1L
5 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Caplin Point Lab Share Price
Caplin Point Lab
Pharmaceuticals
Add Stock
Add Another

Caplin Point Lab Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.